Equities research analysts predict that Encompass Health Corp (NYSE:EHC) will report $1.09 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Encompass Health’s earnings, with the highest sales estimate coming in at $1.13 billion and the lowest estimate coming in at $1.08 billion. Encompass Health posted sales of $1.02 billion in the same quarter last year, which suggests a positive year over year growth rate of 6.9%. The business is scheduled to announce its next quarterly earnings results on Monday, February 25th.
According to Zacks, analysts expect that Encompass Health will report full year sales of $4.27 billion for the current year, with estimates ranging from $4.26 billion to $4.31 billion. For the next fiscal year, analysts expect that the firm will report sales of $4.53 billion, with estimates ranging from $4.49 billion to $4.56 billion. Zacks’ sales calculations are an average based on a survey of research firms that cover Encompass Health.
Several brokerages have recently weighed in on EHC. Mizuho reissued a “buy” rating and set a $82.00 price objective on shares of Encompass Health in a report on Thursday, July 26th. Credit Suisse Group lifted their price objective on Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, July 26th. Finally, Piper Jaffray Companies raised Encompass Health from a “neutral” rating to an “overweight” rating in a report on Thursday, July 26th. One investment analyst has rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Encompass Health currently has a consensus rating of “Buy” and a consensus price target of $73.00.
NYSE EHC traded down $0.71 during trading on Monday, hitting $73.22. The company’s stock had a trading volume of 774,465 shares, compared to its average volume of 862,592. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 1.58. The company has a market cap of $7.26 billion, a P/E ratio of 26.53, a P/E/G ratio of 1.86 and a beta of 0.49. Encompass Health has a 52 week low of $47.32 and a 52 week high of $82.46.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Wednesday, January 2nd will be issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 1.48%. The ex-dividend date of this dividend is Monday, December 31st. Encompass Health’s payout ratio is presently 39.13%.
Encompass Health Company Profile
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Featured Story: How to Invest in Marijuana Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.